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ABSTRACT 
Mentha piperita is a natural hybrid of water mint (Mentha aquatica) and spearmint (Mentha spicata L.), that are consumed as 
tisanes. For that reason, the present work evaluated physicochemical and microbiological aspects for the quality control of a 
commercial brand of Mentha piperita herbal tea distributed in Costa Rica, using assays established by the Central American 
Technical Regulation (RTCA) 11.03.56.09 (Pharmaceutical products. Natural medicinal products for human use. Quality 
verification), and determined if they have uniformity for different batches of this brand. To verify the quality of three batches of this 
product, the following assays were done: Labeling requirements, organoleptic, minimum fill, foreign organic matter, loss on drying, 
total ash, acid-insoluble ash, lead and arsenic limits, microbial enumerations and specific microorganisms (E. coli and Salmonella 
sp.) assays. As conclusion, the batches were in compliance for all the assays, except for labeling test, since information 
corresponding to the primary (batch number and expiration date) and secondary packaging (qualitative-quantitative composition of 
active ingredients, interactions and adverse effects) were not presented. Furthermore, one of the batches did not have information 
about the employment, contraindications and warnings. Also, the manufacturing company maintained a good reproducibility 
between one batch and another, and the improvements that can be made are in the product labeling and better controls in its filling. 
Keywords: Natural product, Mentha piperita, quality control, tisane, pharmacopoeia, Central American Technical Regulation. 
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INTRODUCTION 
Since the beginning of humanity, individuals have been 
given the task of exploiting the environment. Plants have 
become an important component, especially those for 
medicinal use
1
. Through various studies, the benefits of 
natural products with pharmacological properties have 
been proven in the well-being and health conservation
2
. 
One of these products is peppermint, whose scientific 
name is Mentha piperita. This plant belongs to the 
Lamiaceae family
3
, it grows in Europe, North America 
and North Africa temperate climates
4
, and is a natural 
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hybrid of water mint (Mentha aquatica) and spearmint 
(Mentha spicata L.)
5, 6
. It has been reported to possess 
many properties, including antimicrobial, anti-
inflammatory, medium anesthetic, antispasmodic, 
antiulcer, cytoprotective and hepatoprotective
7
, 
antioxidant, antidiabetic and antitumor
8
. In addition, the 
aqueous extract of its leaves has demonstrated 
significant antiviral activity against viruses: Influenza A, 
Newcastle, Herpes Simplex, Vaccinia and West Nile in 
egg and cell cultures
9
. These qualities, together with its 
aromaticity and therapeutic effects, have opened the way 
for its use in the pharmaceutical industry for the 
development of cosmetics, medicines and personal care 
products
10
. However, its presentation and preparation 
influence the amount of active ingredient or natural 
product available at the time of consumption, affecting 
its therapeutic effect
11
. 
One of the consumption forms of peppermint is through 
the tisanes use. The popularity of these herbal beverages 
is mainly due to the high availability of herbal teas and 
medicinal plant formulations, their low price, and the 
virtual absence of side effects and biological 
aggressiveness, and a recent trend observed regarding 
with their use as replacement or complement for 
medicines and traditional drugs
12
. Precisely because of 
these advantages, there is usually no control over the 
ingested quantity, as well as the populations that could 
present a greater susceptibility to a certain active 
principle and, therefore, have an undesired effect. In 
addition, their compounds can vary their content 
qualitatively and quantitatively in the different batches 
sold, since the raw material can be found in different 
environmental conditions
13
. Other important factors that 
may compromise the herbal teas quality is the 
inadvertent contamination by microbial or chemical 
agents during any of the production stages and the 
substitution of the authentic plant (substitution by a 
different vegetable species or an incorrect part of the 
plant)
14
. Therefore, quality control of these products is 
necessary. Thus, its use and its commercialization in any 
market will comply with the quality, safety and efficacy 
standards stipulated in the national regulations. 
In this way, the present work evaluated physicochemical 
and biological aspects for the quality control of a 
commercial brand of Mentha piperita herbal tea 
distributed in Costa Rica, using assays established by the 
Central American Technical Regulation (RTCA) 
11.03.56.09 (Pharmaceutical products. Natural 
medicinal products for human use. Quality 
verification)
15
, and determined if they have uniformity 
for different batches of this brand. 
MATERIALS AND METHODS 
Sampling and selection of quality control assays 
Three batches of Mentha piperita tisanes were sampled 
(five boxes of each one), whose brand is commercialized 
in Costa Rica. These batches were obtained in different 
national supermarkets located in the Great Metropolitan 
Area. The assays performed are established by RTCA 
11.03.56.09
15
. In this regulation, it is established that the 
requirement to use a procedure of a certain requested 
assay is that it is in an official book for Costa Rican 
regulations. 
 
Labeling requirements 
The four items of the primary packaging and the 19 
items of the secondary packaging indicated in the RTCA 
11.04.41.06 (Natural medicinal products for human use. 
Labeling requirements)
16
 were evaluated. They are 
shown in Table 1. 
Organoleptic assays 
The odor, color, and flavor characteristics were 
determined from ten tisanes of the three available 
batches, as indicated in the British Pharmacopoeia 
2016
17
. The content of the tisanes had to have a 
characteristic and Penetrating smell, as well as a moss 
green color and an aromatic flavor. 
Minimum fill assay 
The procedure of the general chapter <755> of the 
United States Pharmacopeia (USP) 40
18
 was carried out. 
A sample of 10 tisanes was selected and each of the 
envelope content was individually weighed on an 
Adam® PW 254 analytical balance. The net content of 
the 10 tisanes should not be less than the declared 
amount, and the net content of any individual envelope 
should not be less than 90 % of the declared amount. 
Determination of foreign organic matter 
The foreign matter test was carried out according to the 
British Pharmacopoeia 2016
17
. The inspection of foreign 
material was carried out with the help of a Magnifier 
Lamp® 8611A-D and the exact weight was determined 
using an ADAM® PW 254 analytical balance. The 
criteria established that a maximum of 5 % of stems and 
a maximum of 2 % of foreign matter should be obtained. 
Loss on drying assay 
The procedure of the general chapter MGA-FH 0080 of 
the Herbalist Pharmacopoeia of the Mexican United 
States was done
19
. Around 3 g of each of the batches 
was accurately weighed using the ADAM® PW 254 
analytical balance, using a melting pot that was 
previously brought to constant weight. Then, the melting 
pot with the sample was placed in a Thermo Scientific® 
Heratherm OG5 100 oven at a temperature of 105 °C for 
two hours. Subsequently, it was cooled in a desiccator 
and then the melting pot was weighed again with the 
dried sample to calculate the lost percentage. The sample 
should be dried until two consecutive weights did not 
differ by more than 0,0005 g. The lost percentage should 
not be greater than 15 %. 
Total ash assay 
The procedure of the general chapter MGA-FH 0060 of 
the Herbalist Pharmacopoeia of the Mexican United 
States was followed
19
. Around 2 g of the tisane sample 
of each batch was accurately weighed on an ADAM® 
PW 254 analytical balance, in a melting pot previously 
brought to constant weight. Then, the material was 
incinerated by gradually increasing the temperature to 
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600 °C in a Thermo Scientific® F47915 muffle furnace, 
for two hours. Subsequently, it was cooled in a 
desiccator for 30 minutes and the weight of the ashes 
was determined using the analytical balance. After that, 
the samples were continued drying until the difference 
of two weights was less than 0,0005 g. The acceptance 
criteria implied that the percentage of total ash should 
not be greater than 15 %. 
Acid-insoluble ash assay 
The procedure of the general chapter MGA-FH 0060 of 
the Herbalist Pharmacopoeia of the Mexican United 
States was carried out
19
. To each of the total ash samples 
obtained from the previous test, 25 ml of 3 N 
hydrochloric acid was added. Then, they were covered 
with a watch glass and heated to boiling for 5 minutes. 
Next, the insoluble material was collected on a Boeco® 
grade 389 filter paper, which was then washed with hot 
water. Subsequently, the filter paper containing the 
insoluble material was transferred to the melting pot, 
which was previously brought to constant weight. Then, 
it was incinerated for two hours at a temperature of 600 
°C in a Thermo Scientific® F47915 muffle furnace. 
Subsequently, it was cooled in a desiccator for 30 
minutes and the weight of the acid-insoluble ashes was 
determined using an ADAM® PW 254 analytical 
balance. After that, the samples were continued drying 
until the difference of two weights was less than 0,0005 
g. The acceptance criteria implied that the insoluble ash 
percentage should not be more than 1,5 %. 
Heavy metal limit assay (lead) 
The evaluation of heavy metals was made according to 
the procedure described for method A in the general 
chapter 2.4.8 of the European Pharmacopoeia 5.0
20
. For 
each batch sample, two tisanes were taken and 22,00 ml 
of distilled water were added. It was left to rest for 5 
minutes and after this time, the tisanes liquid was 
extracted by compressing them the maximum, pouring it 
in the same beaker. After this, an aliquot of 12,00 ml 
was taken for the sample, of 2,00 ml for the standard and 
of 2,00 ml for the blank, which were poured in test 
tubes. 10,00 ml of lead standard (1 ppm) was added to 
the tube used for the standard and 10,00 ml of distilled 
water for the tube used for the blank, respectively. Next, 
2 ml of acetic acid-sodium acetate buffer (pH 3,5), 0,5 
ml of dilute acetic acid and 1,2 ml of thioacetamide 
solution (previously heated in a steam bath) were added 
to each tube. The result was consistent if both the blank 
and the sample had a brown color of less intensity than 
the pattern. 
Arsenic determination limit assay 
The test was carried out according to the procedure 
described for method A in the general chapter 2.4.2 of 
the European Pharmacopoeia 5.0
20
. In a beaker the 
tisane was placed and 11,00 ml of distilled water was 
added. It was left to rest for 5 minutes and after this time 
the tisane was extracted, compressing as much as 
possible to pour the liquid in the same beaker. After this, 
an aliquot of 10,00 ml was taken and placed in a conical 
flask. Then, 15 ml of 12 M HCl, 0,1 ml of stannous 
chloride and 5 ml of potassium iodide 16 %w/v were 
added. It was allowed to stand for 15 minutes and then 3 
g of zinc were added to heavy chips on a Sartorius® M-
prove scale balance. Next, the two parts of the apparatus 
were assembled and the flask was placed in a water bath 
with a temperature range between 90 and 100 °C. The 
standard was prepared in the same way, using 1,00 ml of 
arsenic standard solution (1 ppm). After two hours, the 
stain produced on the mercury bromide paper in the 
sample should not be more intense than that of the 
reference standard. 
Microbial enumeration assay 
The procedure of general chapter <2021> of USP 40 
was performed employing the plate count method
18
. For 
the total aerobic microorganism enumeration, a sample 
of 10 g of each of the batches was taken and dissolved in 
90 ml of Bacto
TM
 casein-soybean digest broth. Then, two 
Petri dishes were prepared for each culture medium 
(Bacto
TM
 casein-soybean digest agar for mesophilic 
microorganisms and Liofilchem
TM
 potato dextrose agar 
for filamentous fungi and yeasts), according to an 
appropriate dilution for the subsequent counting. The 
Petri dishes with casein-soybean digest agar were 
incubated at a temperature of 33 °C for 48 hours, while 
those of potato dextrose agar were incubated at 22,5 °C 
for 5 days. After the incubation, the colony forming 
units present in each of the dishes were counted, the 
arithmetic mean of the counts for each of the culture 
media was calculated and the number of colony forming 
units (CFU) per gram of product was determined. 
According to RTCA 11.03.56:09
15
, the product is in 
compliance if the total aerobic microorganism 
enumeration does not exceed 10
7
 CFU/gram of product 
and the filamentous fungi and yeast enumeration does 
not exceed 10
5
 CFU/gram of product. 
Specific microorganisms assays 
The procedure of general chapter <2022> of USP 38 
was carried out for the determination of the presence of 
Salmonella sp. and E. coli
18
. 
E. coli absence assay 
Around 10 g sample of each batch were transferred to a 
flask with 90 ml of Bacto
TM
 casein-soybean digest broth. 
Subsequently, the sample was incubated at a temperature 
of 33 °C for 24 hours. Next, a 1,00 ml sample aliquot 
was taken to a flask with 100 ml MacConkey broth, 
mixed and incubated at 44 °C for 24 hours. After this 
period, a 1,00 ml sample was taken to inoculate two 
MacConkey agar Petri dishes. The dishes were 
incubated at 33 °C for 24 hours and after that, the dishes 
were examined. According to RTCA 11.03.56:09
15
, the 
product is in compliance with the E. coli absence. 
Salmonella sp. absence assay 
From the sample prepared for the absence of E. coli 
assay, an 1,00 ml aliquot of each batch sample was taken 
and added to 10,00 ml of Difco
TM
 Rappaport Vassiliadis 
Salmonella enrichment broth. It was mixed and 
incubated at a temperature of 33 °C for 24 hours. Then, 
a 1,00 ml sample was taken to inoculate two Petri dishes 
of Difco
TM
 xylose lysine deoxycholate agar. These were 
incubated at a temperature of 33 °C for 24 hours and the 
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inoculated plates were examined. According to the 
RTCA 11.03.56:09
15
, the product is in compliance in 
case of Salmonella sp absence. 
RESULTS AND DISCUSSION 
To begin the evaluation of the quality of the three 
batches of a peppermint tisanes brand commercialized in 
Costa Rica, a checklist was developed. In this way, it is 
possible to check the presence of the labeling 
information in the primary and secondary packages, as 
shown in Table 1. The information present on the 
labeling allows the consumer to make conscious and 
informed use of the product. Therefore, it must be easy 
to read and understand, and thus, allow the transmission 
of information to be effective
21
. Incorrect labeling with 
unclear or absent information can lead to dosage 
confusions, treatment discontinuations, incorrect 
administration, and many other inconveniences and 
errors that can generate a risk to the people´s health
22
. 
As of the review carried out, the three batches lack 
important information about the batch number and 
expiration date for the primary package. The expiration 
date marks the point at which the active ingredient has 
not been tested in a longer time in terms of safety and 
efficacy
23
. Its absence may endanger the consumer 
safety, given that if the product is consumed subsequent 
to it, it is not possible to ensure its microbiological and 
physical stability, as well as its declared nutritional 
content
24
. In addition, by not presenting the batch 
number it would be impossible to determine the tisane 
consumed tisane origin and in case of any 
inconvenience, it would not be possible to remove the 
rest of the product, since the batch to which it belongs is 
not known
25
. 
In the case of secondary packaging, no information was 
found regarding the quali-quantitative composition of 
the active ingredients (including scientific name), the 
interactions and the adverse effects associated with the 
use of the product (Table 1). In addition, the labeling of 
batch 3 did not have information about the use mode and 
the contraindications. In the case of the active 
ingredients, the information is essential, given that this 
medicinal plant has different active ingredients that 
generate its pharmacological effect, and that can be 
found in distinct concentrations. The essential oils are 
menthol (33-60 %), menthone (15-32 %), isomenthone 
(2-8 %), 1,8-cineole or eucalyptol (5-13 %), menthyl 
acetate (2-11 %), pulegone (0,5-1,6 %) and carvone (1 
%). It is important to mention that these values vary 
according to environmental factors such as plant 
maturity, variety, geographical region and processing 
conditions
26
. 
Regarding the interactions, it is known that peppermint 
oil can orally increase blood levels of felodipine and 
simvastatin, as well as cyclosporine. It can also interfere 
with the processing of certain drugs that use the 
cytochrome P450
27, 28
. Other possible interactions are 
with antacids, calcium channel blockers and drugs that 
lower blood pressure
27
, as well as with warfarin
29
. 
Regarding the adverse effects, it is indicated that they 
are claimed to be usually mild, such as gastro 
esophageal reflux, heartburns, nausea, vomiting, allergic 
reactions and diarrhea
30
. In other words, it has a 
relatively low profile of adverse effects, which makes it 
a favorable treatment
31, 32
. 
As for the organoleptic characteristics, it was found that 
the three batches were in compliance with the 
specifications established in the British 
Pharmacopoeia
17
. These characteristics are determined 
according to the similarities and differences of the 
organoleptic properties described objectively for a 
plant
33
. These characteristics allow determining the 
degree of adulteration of the raw material, which can 
cause health and safety concerns and have implications 
for public health
34
. With the assays, it was obtained that 
the three samples of the analyzed batches showed moss 
green color and a penetrating smell, as well as the 
aromatic flavor. This is consistent with that established 
in the literature used. In addition, in the ten tisanes 
evaluated for each batch, other characteristics of the 
leaves could not be observed, such as the presence of 
purple veins
35
, due to the degree of crushing of the raw 
material.
 
Table 1: Results of the labeling assay of the primary and secondary packaging items for three batches of a brand of 
Mentha piperita tisanes commercialized in Costa Rica. 
Required information 
Fulfillment 
Batch 1 Batch 2 Batch 3 
Primary packaging 
Brand name Yes Yes Yes 
Batch number No No No 
Expiration date No No No 
Manufacturer laboratory name or logo Yes Yes Yes 
Secondary packaging 
Product name Yes Yes Yes 
Pharmaceutical form Yes Yes Yes 
Indications Yes Yes Yes 
Employment form Yes Yes No 
Quali-quantitative composition of active ingredients No No No 
Registration number Yes Yes Yes 
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Manufacturer name and country of origin Yes Yes Yes 
Net amount of the finished product Yes Yes Yes 
Batch number Yes Yes Yes 
Storage conditions Yes Yes Yes 
Expiration date Yes Yes Yes 
Contraindications and warnings Yes Yes No 
Interactions No No No 
Adverse effects No No No 
General labeling Yes Yes Yes 
Special labeling Yes Yes Yes 
Posology Yes Yes Yes 
Administration route Yes Yes Yes 
Use during pregnancy, breastfeeding, erlderly and children under 2 
years 
Yes Yes Yes 
 
On the other hand, the results for the minimum fill assay 
are shown in Table 2. They denote that the net content 
of the 10 tisanes of each of the used batches was not less 
than the declared amount. Also, the net content of each 
individual tisane was not less than 90 % of the declared 
amount, so the three batches are in accordance with the 
specifications of USP 40
18
. However, it is not specified 
which is the maximum that the samples can contain with 
respect to the declared labeling. For batches 1 and 2, 
there was not a very distant average with respect to the 
labeling. But, in the case of batch 3, the average of the 
ten tisanes was 1,4884 g, that is 13 % of excess with 
respect to that indicated on the product secondary 
packaging. 
In the absence of a maximum limit, it can not be 
determined if this batch would be rejected in a quality 
control. This absence is worrisome, because as with 
drugs in general, there is a therapeutic range, which is a 
ratio that compares the blood concentration at which a 
drug causes a therapeutic effect with respect to the 
amount that causes death (in studies animals) or toxicity 
(in human studies)
36
. According to the literature, the 
usual dose for peppermint corresponds to 1,5 to 3 g 
three times a day as an infusion (adults), 3 to 5 g daily 
(children from 4 to 10 years) and 3 to 6 g (children of 10 
to 16 years)
37
. Along with this, it is known that high 
doses of Mentha piperita can be hepatotoxic and 
nephrotoxic, and even cause interstitial nephritis and 
acute renal failure
30
. Therefore, it is advisable to 
evaluate the effect of the excess of tisane in the 
consuming population and to evaluate whether by using 
more stringent statistical controls in the filling process 
of the herbal teas, it would be possible to decrease this 
variation
38
.
 
Table 2: Results of the minimum fill assay for different batches of a Mentha piperita tisanes brand commercialized in 
Costa Rica. 
Tisane Batch 1 Batch 2 Batch 3 
Weight (g) Labeling 
percentage (%) 
Weight (g) Labeling 
percentage (%) 
Weight (g) Labeling 
percentage (%) 
1 1,3453 103 1,3607 105 1,4640 113 
2 1,3627 105 1,3870 107 1,4966 115 
3 1,3194 101 1,3640 105 1,4521 112 
4 1,2794 98 1,3774 106 1,4408 111 
5 1,3519 104 1,3444 103 1,5398 118 
6 1,3410 103 1,3567 104 1,5202 117 
7 1,3237 102 1,3648 105 1,5053 116 
8 1,3253 102 1,3817 106 1,4811 114 
9 1,2803 98 1,4083 108 1,5028 116 
10 1,3312 102 1,2509 96 1,4808 114 
Mean value 1,3260 102 1,3596 105 1,4884 114 
 
With reference to the determination of foreign organs 
and foreign matter, both components were separated and 
weighed. The data obtained is shown in Table 3. The 
percentage of foreign organs was between 0,1 and 0,5 % 
for the three analyzed batches, while for foreign matters 
it was found between 0,2 and 0,3 %. The final result of 
this assay was in compliance of the three batches. It 
should be mentioned that in batch 1 small stones, red 
seeds and a small arthropod were found, while for the 
other two, only small stones were seen. As for foreign 
organs, it was possible to appreciate woody tissues and 
stems in the three batches. This determination is 
relevant, because it ensures that the stated herbal drugs 
were made from the specific part of the plant and are 
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devoid of other parts of the same plant or other plants. If 
values higher than those established for the 
pharmacopoeia are found, this may mean the natural 
product adulteration. From the point of view of natural 
products, adulterations may involve both the presence of 
a part of the plant other than the recommended or the 
presence of dust, mold, whole insects, fragments thereof 
or other plants
39
. Regardless of the adulteration found, 
the final result is obtaining a product with a quality, 
safety and efficacy lower than required. 
 
Table 3: Foreign organs and foreign matter in samples of 10 tisanes for three different batches of a Mentha piperita 
tisanes brand commercialized in Costa Rica. 
Batch Initial sample 
weight (g) 
Foreign organs 
weight (g) 
Foreign organs 
percentage (%) 
Foreign matter 
weight (g) 
Foreign matter 
percentage (%) 
1 13,6242 0,0742 0,5 0,0306 0,2 
2 13,5419 0,0548 0,4 0,0463 0,3 
3 14,6422 0,0214 0,1 0,0281 0,2 
 
For the loss on drying assay, values of 9,6, 9,8 and 10,1 
% were obtained (Table 4), which are below the 
maximum value established by the Herbalist 
Pharmacopoeia of the Mexican United States. Therefore, 
the three batches of Mentha piperita tisanes 
commercialized in Costa Rica were found to be in 
compliance for this assay. This has been cataloged as an 
older, critical and fundamental unit operation technique 
for the postharvest conservation of medicinal plants
40
. 
The importance of this amount of water is due that the 
reduction of the product moisture content below a 
certain value reduces the physicochemical and 
microbiological deterioration of the product and allows 
its storage in a stable condition, increasing the useful life 
of the final product
41,42
. Therefore, it represents one of 
the best alternatives to increase its stability. These values 
reaffirm the results that were obtained in the 
microbiological tests, as will be discussed later. 
 
Table 4: Loss on drying percentage of the different evaluated batches of a brand of Mentha piperita tisanes 
commercialized in Costa Rica. 
Batch Initial weight (g) Final weight (g) Loss on drying percentage (%) 
1 2,8136 2,5305 10,1 
2 2,6930 2,4282 9,8 
3 2,6384 2,3838 9,6 
 
In relation with the results obtained for the total ash and 
insoluble-acid ash assays, both showed lower values for 
all the analyzed batches than established by this same 
pharmacopoeia, being between 8,1 and 9,6 %, and 
between 0,5 and 0, 6 % for total ash and insoluble-acid 
ash, respectively. In this way, there was compliance for 
both assays in each of the analyzed batches. The 
information is summarized in Table 5. The 
determination of total ash reveals the content of mineral 
salts or inorganic matter present in the tisane, which 
could be physiological (coming from the mineral 
components of the plant itself) or derived from foreign 
matter that is attached to the surface of the product
43
. On 
the other hand, the procedure to determine acid insoluble 
ashes from the incineration of the peppermint tisane 
under study measures the amount of silica present in the 
sample, especially in the form of sand and siliceous 
earth
44
. Therefore, both methods are simple and 
important to evaluate the quality and purity of herbal 
medicine
45
. In summary, no significant contamination 
was obtained from inorganic matter and mineral salts in 
the Mentha piperita tisanes. This shows that the 
necessary care during the manufacturing process did 
exist. It is essential to mention that the presence of more 
of these ashes with respect to the established also means 
adulteration, contamination, substitution or neglect in 
the preparation of the product
46
. 
 
Table 5: Total ash and insoluble-acid ash percentages of the different evaluated batches of a brand of Mentha piperita 
tisanes commercialized in Costa Rica. 
Batch Initial weight 
(g) 
Total ash weight 
(g) 
Total ash 
percentage (%) 
Insoluble-acid ash 
weight (g) 
Insoluble-acid ash 
percentage (%) 
1 2,7186 0,2209 8,1 0,0154 0,6 
2 2,2058 0,2117 9,6 0,0116 0,5 
3 2,7389 0,2242 8,2 0,0159 0,6 
 
Other quality control assays carried out were those 
corresponding to the limit assays for the lead and arsenic 
determinations. Various items including foods have been 
found to contain toxic compounds, including these 
mentioned
47
. Both metals contained in this type of herbal 
products enter the human body and can cause negative 
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effects over the normal functions of different organs and 
systems, such as central nervous system, liver, lungs, 
heart, kidney and brain, leading to hypertension, 
abdominal pain, skin eruptions, intestinal ulcer and 
different types of cancer
48
. In the case of lead, is a heavy 
metal that is stored in bone, blood and soft tissues (brain, 
spleen, kidneys, liver, and lungs). Its presence leads to 
the production of free radicals that causes oxidative 
damage of cellular components, and interferes DNA 
transcription, vitamin D synthesis, and enzymes function 
that maintains the cell membranes integrity
49
. Other 
symptoms related to the lead poisoning are abdominal 
pain, arthralgia, muscle stiffness, anorexia, weight loss, 
tiredness, lethargy, insomnia, headache, neuritis, 
convulsions, delirium tremens, coma, renal failure, 
hypertension, encephalopathy, psychological and 
behavioral changes
50
. In the case of the conducted assay 
for this heavy metal, the three studied batches were in 
compliance according to the European Pharmacopeia, 
because the lead standard exhibited a less intense color 
precipitate in comparison with the samples of these 
batches.  
Furthermore, for the arsenic test, the three batches of 
peppermint tisanes were also found according to what 
was indicated in the European Pharmacopoeia, that is, it 
was lower than the allowed limit. This was due to the 
fact that none showed a more intense color stain with 
respect to the arsenic pattern. The assay is made because 
arsenic can be found in the groundwater, frequently used 
for human consumption, as well as for crops irrigation
51
. 
Therefore, the arsenic contamination in groundwater is a 
serious public health threat worldwide
52
. In terrestrial 
environment, the inorganic forms of As (trivalent 
arsenite (As
3+
) and pentavalent arsenate (As
5+
)) are more 
prevalent and toxic than the organic forms in general. Its 
ingestion causes effects on general protein metabolism 
by reacting with sulfhydryl groups existing in cysteine 
residues
53
. The ingested arsenic can cause lung, bladder 
and skin cancer in humans
54
. 
Finally, the microbial enumerations of mesophilic 
aerobic microorganisms, as well as of filamentous fungi 
and yeasts were made. These assays are developed since 
soil contamination can cause microbial contamination of 
herbal products. Likewise, after harvesting, 
microorganisms can grow and cause spoilage or even 
produce toxins during transport and storage if the 
conditions, mainly temperature and water content, are 
favorable
55
. Microbiological assessment of non-sterile 
products can reduce or even eliminate the therapeutic 
effect of drugs or cause drug-induced infections, because 
they can change the chemical, physical and organoleptic 
properties of the drugs or change the contents of active 
ingredients. Furthermore, microorganisms can convert 
drugs to toxic products
56
. In the case of samples from the 
three batches evaluated, a smaller number of CFU per 
gram of product was found with respect to the limit 
established by RTCA 11.03.56:09
15
. Therefore, all of 
them were satisfied for the presence of these 
microorganisms. The presence of acceptable quantities 
of bacteria, fungi and yeasts in the product is indicative 
of Good Manufacturing Practices (GMP) in conjunction 
with the use of resources in good state and in the 
adequate conditions. 
Regarding the specific microorganisms, in all the three 
samples of the analyzed batches of Mentha piperita 
there was an absence of E. coli and Salmonella sp. The 
E. coli is an important cause of infectious diarrhea
57
. 
This poisoning is caused by the Shiga toxin, which 
generates in patients a picture of abdominal cramps and 
diarrhea that can progress to bloody diarrhea
58
. 
In the case of Salmonella sp., its infection may be 
manifested as gastroenteritis, septicemia, or enteric 
fever. Enteric fevers are caused by the human-specific 
pathogens S. enterica serovars typhi and paratyphi. 
Infection severity may vary by the resistance of each 
individual and the immune system as well as the 
virulence of Salmonella isolate
59,60
. In the case of this 
last bacterium, the RTCA does not establish an assay for 
its absence for products that are consumed after the 
addition of boiled water (because the bacteria are not 
able to resist boiling water). However, because people in 
Costa Rica use hot water instead of boiling water, it is 
better to determine the presence or absence of this 
pathogen in order to provide a greater security to the 
consumers of peppermint tisanes.  
CONCLUSIONS 
The three batches of the M. piperita tisanes used to 
perform the quality control assays were in compliance 
with the organoleptic, minimum fill, loss on drying, total 
ash, insoluble-acid ash, foreign organic matter, and 
arsenic and lead limits assays, according to the different 
official books used. In addition, the limits of total 
enumerations of mesophilic aerobic microorganisms, 
filamentous fungus, and yeasts were fulfillment. Finally, 
there was an absence of Escherichia coli and Salmonella 
sp. 
Nonetheless, nonconformities were found for the criteria 
established by the RTCA for the labeling test, since 
information corresponding to the primary and secondary 
packaging was missing. In the case of primary 
packaging, there was absence of the batch number and 
the expiration date, while the secondary packaging did 
not present fundamental aspects such as the qualitative-
quantitative composition of active ingredients (including 
scientific name), interactions and adverse effects. The 
third batch did not have information about the 
employment form, contraindications and warnings. 
The importance of this information is that, at least in the 
case of this brand of peppermint tisanes, the 
manufacturing company maintained a good 
reproducibility between one batch and another. The 
improvements that can be made are in the product 
labeling and better controls in its filling. 
Finally, it is expected to continue this research with 
other raw materials used in Costa Rica in this 
pharmaceutical form, that have information in different 
pharmacopoeias and official books. This is because the 
compliance of a product cannot ensure that for others the 
results will be the same. 
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